Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis
Moreno Cuevas, Jorge E.
González Garza y Barrón, María T.
Rodríguez Montalvo, Carlos
Cruz Vega, Delia E.
DisciplineCiencias de la Salud / Health Sciences
MetadataShow full item record
AbstractAbstract During chronic liver injury, hepatic stellate cells (HSC) are activated and proliferate, which causes excessive extracellular matrix (ECM) deposition, leading to scar formation and fibrosis. Medicinal plants are gaining popularity as antifibrotic agents, and are often safe, cost-effective, and versatile. This review aims to describe the protective role and mechanisms of medicinal plants in the inhibition of HSC activation and ECM deposition during the pathogenesis of liver fibrosis. A systematic literature review on the anti-fibrotic mechanisms of hepatoprotective plants was performed in PubMed, which yielded articles about twelve relevant plants. Many of these plants act via disruption of the transforming growth factor beta 1 signaling pathway, possibly through reduction in oxidative stress. This reduction could explain the inhibition of HSC activation and reduction in ECM deposition. Medicinal plants could be a source of anti-liver fibrosis compounds.
TypeArtículo / Article
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/4.0/
- Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cells.
- Authors: Duval F, Moreno-Cuevas JE, González-Garza MT, Rodríguez-Montalvo C, Cruz-Vega DE
- Issue date: 2014
- Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response.
- Authors: Duval F, Moreno-Cuevas JE, González-Garza MT, Maldonado-Bernal C, Cruz-Vega DE
- Issue date: 2015
- The antifibrogenic effect of (-)-epigallocatechin gallate results from the induction of de novo synthesis of glutathione in passaged rat hepatic stellate cells.
- Authors: Yumei F, Zhou Y, Zheng S, Chen A
- Issue date: 2006 Jul
- Targeting Mechanotransduction at the Transcriptional Level: YAP and BRD4 Are Novel Therapeutic Targets for the Reversal of Liver Fibrosis.
- Authors: Zhubanchaliyev A, Temirbekuly A, Kongrtay K, Wanshura LC, Kunz J
- Issue date: 2016
- Cooperation of liver cells in health and disease.
- Authors: Kmieć Z
- Issue date: 2001